Veterinary Vaccines Market Poised for Strong Growth Amid Rising Animal Welfare Awareness

Strategic Insights -

The veterinary vaccines market is witnessing significant growth, driven by increasing awareness of animal welfare and the rising demand for ethical and sustainable animal products. According to a report, the market was valued at USD 8.44 billion in 2024 and is expected to reach USD 12.76 billion by 2030, growing at a CAGR of 7.28%. The market plays a critical role in ensuring animal health, maintaining food security, and reducing the risk of zoonotic disease transmission.

Key Takeaways:

  • The veterinary vaccines market is driven by growing awareness of animal welfare, with pet owners prioritizing routine vaccinations to extend the life and quality of their pets.
  • Regulatory frameworks and animal welfare certifications increasingly include vaccine requirements as part of disease prevention protocols, shaping market demand.
  • The European Medicines Agency's 2024 certification of the Innovax vPTMF vaccine platform demonstrates the industry's commitment to rapid response and improved vaccine accessibility.
  • The market faces challenges such as regulatory hurdles and approval processes, with varying standards across global regions and complex approval processes.
  • The trend of preventive healthcare through vaccination is reshaping the approach to animal care, prioritizing early intervention and long-term health maintenance in both the companion animal and livestock sectors.

Statistics:

  • The veterinary vaccines market is expected to reach USD 12.76 billion by 2030, growing at a CAGR of 7.28%.
  • The market was valued at USD 8.44 billion in 2024.
  • The demand for ethical and sustainable animal products is driving market expansion.
  • The European Medicines Agency's certification of the Innovax vPTMF vaccine platform in 2024 highlights the industry's commitment to rapid response and improved vaccine accessibility.
  • Preventive healthcare is viewed as a strategic investment in the companion animal sector, with routine vaccinations becoming standard.
  • Investor-owned animal healthcare companies like Zoetis Inc., Merck & Co. Inc., and Virbac SA are key players in the market.

Sources:

  • ResearchAndMarkets.com's "Veterinary Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F"
  • European Medicines Agency's certification of the Innovax vPTMF vaccine platform in 2024